For patients with diffuse gliomas, tumor-related epilepsy (TRE) is not a strong prognostic factor, according to a study ...

Anti-aging aficionados have tried it all — including taking certain drugs off-label in the hopes they will lead to longer, ...

Transwell assay showing increased invasion in SNB19 and U251 glioma cells transfected with FAM111B-overexpressing lentivirus, compared to controls. Magnification ×20 Study shows FAM111B overexpression ...

In the largest ever study of its kind, an analysis of entire tumor genomes has provided the most complete picture yet of an ...

In the largest-ever study of its kind, an analysis of entire tumor genomes has provided the most complete picture yet of an ...

HealthDay News — For patients with diffuse gliomas, tumor-related epilepsy (TRE) is not a strong prognostic factor, according to a study published in the May issue of Brain and Behavior.

Oncology specialists from UC San Francisco will present new clinical research findings and cutting-edge treatment strategies at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, ...

The cell of origin for glioma has been an issue for discussion, with evidence pointing to neural stem cells (NSCs), or NSC-derived astrocytes or oligodendrocyte precursor cells (OPCs). Using ...

A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: A report by the RANO resect group. A phase 2 study of pemigatinib for pre-treated glioblastoma or other gliomas ...

A highly decorated, retired Greenwich police officer and US Marine — widely supported by the community during his battle with ...

Engineering PBAE nanoparticles for immunological reprogramming in clinically relevant humanized mouse models. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does ...